B Thomson1, R Tritt, M Davis, M R Kelley. 1. Department of Pediatrics, Indiana University School of Medicine, Indianapolis, USA. bthomson@iupui.edu
Abstract
PURPOSE: DNA repair enzymes have a critical role in cellular maintenance and survival. The enzyme apurinic/apyrimidinic endonuclease/redox factor 1 (APE/ref1), a key protein in the base excision repair pathway, displays both repair and redox control. We examined the role of APE/ref1 in pediatric embryonal and alveolar rhabdomyosarcomas (ARMS). MATERIALS AND METHODS: Using an immunohistochemical method, fixed tissue from 31 newly diagnosed pediatric rhabdomyosarcomas were evaluated for expression of APE/ref1. Tissue was obtained from Indiana University and the Cooperative Human Tissue Network. RESULTS: We demonstrated high levels of expression within the localized and metastatic embryonal rhabdomyosarcomas. This contrasted with both localized and metastatic ARMS, which had low levels of APE/ref1 expression. This histology-specific difference proved to be significant (P = 0.003). Furthermore, the expression within all tumors examined was localized to the nucleus and did not differ between localized and metastatic tumors. CONCLUSIONS: We propose several hypotheses to explain this histology-specific expression of APE/ref1 in pediatric rhabdomyosarcomas. Because the majority of ARMS expressed either the PAX3/FKHR or PAX7/FKHR fusion transcript, the low level of expression may be related to the redox activity of APE/ref1. The low levels may also be related to the bioreductive activity of APE/ref 1.
PURPOSE: DNA repair enzymes have a critical role in cellular maintenance and survival. The enzyme apurinic/apyrimidinic endonuclease/redox factor 1 (APE/ref1), a key protein in the base excision repair pathway, displays both repair and redox control. We examined the role of APE/ref1 in pediatric embryonal and alveolar rhabdomyosarcomas (ARMS). MATERIALS AND METHODS: Using an immunohistochemical method, fixed tissue from 31 newly diagnosed pediatric rhabdomyosarcomas were evaluated for expression of APE/ref1. Tissue was obtained from Indiana University and the Cooperative Human Tissue Network. RESULTS: We demonstrated high levels of expression within the localized and metastatic embryonal rhabdomyosarcomas. This contrasted with both localized and metastatic ARMS, which had low levels of APE/ref1 expression. This histology-specific difference proved to be significant (P = 0.003). Furthermore, the expression within all tumors examined was localized to the nucleus and did not differ between localized and metastatic tumors. CONCLUSIONS: We propose several hypotheses to explain this histology-specific expression of APE/ref1 in pediatric rhabdomyosarcomas. Because the majority of ARMS expressed either the PAX3/FKHR or PAX7/FKHR fusion transcript, the low level of expression may be related to the redox activity of APE/ref1. The low levels may also be related to the bioreductive activity of APE/ref 1.
Authors: Mark R Kelley; Meihua Luo; April Reed; Dian Su; Sarah Delaplane; Richard F Borch; Rodney L Nyland; Michael L Gross; Millie M Georgiadis Journal: Antioxid Redox Signal Date: 2011-01-04 Impact factor: 8.401
Authors: Zhiwei Feng; Stanton Kochanek; David Close; LiRong Wang; Ajay Srinivasan; Abdulrahman A Almehizia; Prema Iyer; Xiang-Qun Xie; Paul A Johnston; Barry Gold Journal: J Chem Biol Date: 2015-04-19
Authors: Srinivasan Madhusudan; Fiona Smart; Paul Shrimpton; Jason L Parsons; Laurence Gardiner; Sue Houlbrook; Denis C Talbot; Timothy Hammonds; Paul A Freemont; Michael J E Sternberg; Grigory L Dianov; Ian D Hickson Journal: Nucleic Acids Res Date: 2005-08-19 Impact factor: 16.971
Authors: In-Youb Chang; Soo-Hyun Kim; Hyun-Ju Cho; Do Young Lee; Mi-Hwa Kim; Myung-Hee Chung; Ho Jin You Journal: Nucleic Acids Res Date: 2005-09-07 Impact factor: 16.971
Authors: S De Summa; R Pinto; B Pilato; D Sambiasi; L Porcelli; G Guida; E Mattioli; A Paradiso; G Merla; L Micale; P De Nittis; S Tommasi Journal: Cell Death Dis Date: 2014-02-20 Impact factor: 8.469